Back

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

28 August 2021 (10:52 - 11:03)
Organised by:
Congress Presentation Part of: Young Investigator Awards Session in Thrombosis Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Mr Fawaz Alenazy

Birmingham (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
JCAD enhances arterial thrombosis by regulating endothelial plasminogen activator inhibitor-1 and tissue factor expression
Doctor L. Liberale (Genova, IT)
Abstract Slides Video
Presentation thumbnail
In vivo coronary artery thrombus imaging with 18F-GP1 PET-CT
Doctor E. Tzolos (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inflammation
Ms L. Willems (Nijmegen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards Session in Thrombosis
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 10:52 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources